Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential trading opportunities before the market opens [1] Premarket Gainers - Olema Pharmaceuticals, Inc. (OLMA) has seen a substantial increase of 213%, trading at $26.68 - Diginex Limited (DGNX) is up 12%, currently priced at $15.25 - Gorilla Technology Group Inc. (GRRR) has risen by 11%, trading at $14.05 - Amer Sports, Inc. (AS) is up 9%, priced at $33.47 - Click Holdings Limited (CLIK) has increased by 9%, trading at $7.38 - Beamr Imaging Ltd. (BMR) is up 9%, currently at $2.14 - James Hardie Industries plc (JHX) has risen by 8%, trading at $18.22 - Arvinas, Inc. (ARVN) is up 8%, priced at $12.00 - Axalta Coating Systems Ltd. (AXTA) has increased by 7%, trading at $30.28 - Genprex, Inc. (GNPX) is up 6%, currently at $4.31 [3] Premarket Losers - LifeMD, Inc. (LFMD) has decreased by 22%, trading at $3.65 - Alpha Technology Group Limited (ATGL) is down 21%, currently priced at $17.00 - Intellinetics, Inc. (INLX) has fallen by 19%, trading at $7.25 - Energizer Holdings, Inc. (ENR) is down 16%, priced at $20.00 - Invivyd, Inc. (IVVD) has decreased by 14%, currently at $2.42 - BellRing Brands, Inc. (BRBR) is down 12%, trading at $22.30 - Sadot Group Inc. (SDOT) has fallen by 9%, currently priced at $3.99 - CEVA, Inc. (CEVA) is down 8%, trading at $21.60 - Helmerich & Payne, Inc. (HP) has decreased by 7%, currently at $25.44 - Opendoor Technologies Inc. (OPEN) is down 5%, trading at $7.39 [4]

Core Insights - Click Holdings Limited announced the acquisition of 100% equity interest in Bowser Human Resources Limited and Top Team Consultants Limited, enhancing its market position in human resources solutions [1][2] - The acquisitions are expected to create immediate synergies, driving operational efficiency and cost reduction across business segments [2] Company Overview - Click Holdings Limited is a leader in AI-powered human resources and senior care solutions, connecting clients with a talent pool of over 23,200 professionals [3] - The company operates in various sectors, including nursing, logistics, and professional services [3] Strategic Growth - The acquisitions are projected to drive approximately 200% growth in sales of the professional services sector and 15% growth in the logistics sector [2] - By leveraging Bowser and Top Team's industry expertise alongside its proprietary AI-powered platform, the company aims to deliver enhanced value to clients in Hong Kong's labor market and Silver Economy [2]

Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential trading opportunities before the market opens [1] Premarket Gainers - Click Holdings Limited (CLIK) is up 81% at $11.17 [3] - Avidity Biosciences, Inc. (RNA) is up 43% at $70.72 [3] - Dyne Therapeutics, Inc. (DYN) is up 37% at $23.58 [3] - Zenas BioPharma, Inc. (ZBIO) is up 21% at $29.00 [3] - ProPetro Holding Corp. (PUMP) is up 18% at $7.47 [3] - PepGen Inc. (PEPG) is up 17% at $5.35 [3] - Unusual Machines, Inc. (UMAC) is up 15% at $14.85 [3] - Semler Scientific, Inc. (SMLR) is up 14% at $27.32 [3] - ETHZilla Corporation (ETHZ) is up 13% at $20.51 [3] - Relmada Therapeutics, Inc. (RLMD) is up 13% at $2.38 [3] Premarket Losers - Smart Logistics Global Limited (SLGB) is down 37% at $3.21 [4] - MaxsMaking Inc. (MAMK) is down 22% at $4.08 [4] - Prenetics Global Limited (PRE) is down 14% at $14.40 [4] - United States Antimony Corporation (UAMY) is down 14% at $10.22 [4] - NeurAxis, Inc. (NRXS) is down 12% at $3.01 [4] - Obook Holdings Inc. (OWLS) is down 9% at $11.39 [4] - Qualigen Therapeutics, Inc. (QLGN) is down 9% at $3.30 [4] - Critical Metals Corp. (CRML) is down 8% at $13.70 [4] - Neuphoria Therapeutics Inc. (NEUP) is down 8% at $5.73 [4] - Beam Therapeutics Inc. (BEAM) is down 7% at $25.86 [4]

Core Insights - Shantou Meiliqi Technology Co., Ltd. has been established with a registered capital of 100,000 RMB [1] - The company is involved in a wide range of activities including technology services, toy manufacturing, and various sales operations [1] Company Overview - The legal representative of the company is Mo Ruihua [1] - The business scope includes technology development, consulting, and transfer, as well as manufacturing and sales of toys, plastic products, stationery, sports equipment, and home goods [1] Business Activities - The company engages in general projects such as technical services, technology promotion, and import-export activities [1] - Specific manufacturing activities include toys, plastic products, stationery, and medical packaging materials [1] - The company also offers professional design services and internet sales, excluding items that require special licenses [1]

Hong Kong, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Click Holdings Limited (“Click Holdings” or “Click” or “we” or “us”, NASDAQ: CLIK) and its subsidiaries (collectively, the “Company”), a leading human resources and senior care solutions provider based in Hong Kong, announced its financial results for the fiscal year ended June 30, 2025. Selected Financial Highlights: Revenue increased 89.3% to HK$83.5 millionNursing solutions and logistics solutions segments each achieved over 200% year-over-year growthGross pro ...

Financial Performance - For FY2023, the net cash provided by operating activities was approximately HK$3.4 million, while for FY2025, it was a net cash used of approximately HK$6.0 million, reflecting a net loss of approximately HK$7.9 million[250][251]. - The net cash used in investing activities for FY2025 was approximately HK$69.1 million, primarily due to the acquisition of a subsidiary, while for FY2023, it was HK$46,932[252][253]. - For FY2025, net cash from financing activities was approximately HK$83.9 million, mainly from the issuance of ordinary shares for general working capital and an initial public offering[254]. Liquidity and Financial Position - The current ratio improved from approximately 1.5 as of June 30, 2024, to 3.0 as of June 30, 2025, indicating enhanced liquidity[246]. - As of June 30, 2025, the company had cash and cash equivalents of approximately HK$10.6 million and current assets of approximately HK$32.4 million[246]. - The Company is exposed to liquidity risk and aims to maintain sufficient liquidity to meet its liabilities under both normal and stressed conditions[380]. - As of June 30, 2025, the Company had no outstanding bank borrowings, indicating a strong liquidity position[381]. - The Company will seek short-term funding from financial institutions if necessary to address liquidity shortages[380]. Capital Expenditures and Investments - Capital expenditures for FY2025 amounted to approximately HK$631,732, compared to HK$46,932 for FY2023[260]. - The company acquired Top Spin, which holds Care U, with a contingent consideration asset recognized at a fair value of HK$1.68 million (US$215,385) on the acquisition date[272][273]. - Goodwill recognized from the acquisition of Top Spin amounted to HKD69,517,007 (US$8,912,437) and was allocated entirely to the Care U reporting unit[284]. Asset Management and Impairment - No impairment of long-lived assets was recognized for the year ended December 31, 2023, and the six months ended June 30, 2024, and the year ended June 30, 2025[281]. - The recoverability of long-lived assets is measured by comparing the carrying amount to future undiscounted net cash flows expected to be generated[281]. - Impairment testing involves significant management judgment, including identifying reporting units and estimating fair values[283]. - Goodwill is tested for impairment annually or more frequently if events indicate potential impairment, following ASC 350 guidelines[283]. - A qualitative assessment post-acquisition indicated that the fair value of the Care U reporting unit exceeded its carrying amount, resulting in no impairment of goodwill[284]. Risk Management - The Company has not been exposed to material risks due to changes in interest rates, although future increases may raise the cost of any debt incurred[381]. - The company did not engage in any material off-balance sheet transactions or arrangements in FY2023 and FY2025[256]. - The company has no research and development activities and relies on trademark law and confidentiality agreements to protect its intellectual property[264][265].

西方媒体罕见集体盛赞中国特高压输电技术，称其破解了能源分布不均的世纪难题。本期视频就来一起 看看中国的"电力奇迹"。 ...

Core Insights - Click Holdings Limited has been accredited as an approved service provider under the Community Care Service Voucher Scheme (CCSV) in Hong Kong, enhancing its position in the elderly care sector [2][4] - The CCSV market is projected to reach HK$1.9 billion, with Click Holdings aiming to become a leader in this sector within two years [3][4] - The company plans to leverage its talent pool of over 22,900 professionals and technology to deliver high-quality services, expecting the CCSV sector to contribute approximately 25% of its overall revenue in two years [4][6] Company Developments - Click Holdings is exploring the integration of cryptocurrency solutions with its senior services, aiming to innovate within the Silver Economy [5] - The company has announced a 1-for-30 share consolidation to comply with listing requirements and improve market sentiment [6] - Click Holdings is the only Nasdaq-listed company focused on senior nursing HR solutions in Hong Kong, positioning itself to benefit from the aging population and government support [6][7] Industry Context - The CCSV empowers elderly residents to choose services that suit their needs, promoting dignity and independence [3] - The Hong Kong government is increasing resources for the CCSV, including expanding eligibility for service vouchers, which enhances the scheme's sustainability and accessibility [4] - There are currently around 200 CCSV service providers, and Click Holdings views this as an opportunity for industry consolidation and reform [4]

Group 1 - Click Holdings Limited has announced the approval of a proposed 1-for-30 share consolidation of its Class A and Class B ordinary shares [1][3] - The share consolidation aims to help the company regain compliance with Nasdaq Marketplace Rule 5550(a)(2) and maintain its listing on the Nasdaq Capital Market [2] - Following the consolidation, the total number of shares outstanding will decrease from 34,362,000 to 1,145,400, with 818,353 Class A Ordinary Shares and 327,047 Class B Ordinary Shares post-consolidation [3] Group 2 - Click Holdings Limited is a leader in AI-powered human resources and senior care solutions, connecting clients with a talent pool of over 20,500 professionals [4]

Core Viewpoint - The research highlights the significant role of lithium in Alzheimer's disease, suggesting that lithium deficiency may be a key driver in the early stages of the disease, and proposes potential therapeutic interventions involving lithium supplementation [6][12][16]. Group 1: Alzheimer's Disease Overview - Alzheimer's disease (AD) is a neurodegenerative disorder characterized by severe cognitive impairment, with approximately 60% to 80% of dementia cases attributed to it [1]. - The disease's pathology includes the accumulation of β-amyloid (Aβ) plaques and tau protein tangles, leading to memory and cognitive decline [1][3]. Group 2: Role of Metals in Alzheimer's Disease - Abnormal accumulation of metals such as iron, copper, and zinc in the brains of Alzheimer's patients has been observed, contributing to oxidative stress and promoting Aβ deposition [4][17]. - Lithium, a less studied metal in this context, has shown potential protective effects against Alzheimer's, with lower levels found in the brains of patients [5][6]. Group 3: Lithium's Mechanism and Research Findings - A study published in Nature confirmed that lithium levels decrease in the brains of Alzheimer's patients, and its deficiency can lead to the activation of GSK3β, exacerbating Aβ accumulation and tau phosphorylation [6][11]. - Animal models demonstrated that lithium supplementation could restore memory function and reduce pathological features associated with Alzheimer's [6][10]. Group 4: Potential Therapeutic Approaches - The research identified lithium as a potential intervention for Alzheimer's, with a specific focus on a lithium compound called lithium lactate, which showed promise in reducing Aβ plaques and tau pathology in mouse models [13][16]. - The study emphasizes the need for further clinical trials to evaluate the efficacy and safety of lithium supplementation in humans [16]. Group 5: Dietary Sources and Implications - Dietary sources of lithium include leafy greens, nuts, legumes, and certain mineral waters, suggesting that a diet rich in these foods may help mitigate dementia risk [16].